week 9 cystic fibrosis and pandemic Flashcards

(41 cards)

1
Q

What is cystic fibrosis (CF)?

A

CF is a genetic disorder caused by mutations in the CFTR gene, leading to thick, sticky mucus in the lungs and other organs, resulting in respiratory infections and organ dysfunction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What gastrointestinal symptoms are common in CF?

A

Pancreatic insufficiency

Bulky/smelly stools

Poor weight gain despite excessive appetite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What causes breathing difficulties in people with CF

A

The mucus in CF is thick and sticky, impairing clearance, trapping bacteria, and leading to inflammation and infections.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the relationship between P. aeruginosa and CF?

A

P. aeruginosa thrives in thick mucus

Forms biofilms that protect it from immune cells and antibiotics

Leads to chronic infection, often starting in childhood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the epidemiology of CF?

A

Most common in white populations

~100,000–180,000 affected globally

Average life expectancy: ~40 years (mutation-dependent)

Treatment cost: $250,000–$350,000/year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does P. aeruginosa impair neutrophil function?

A

Produces toxins that kill neutrophils

Causes release of proteases (e.g. neutrophil elastase)

These cleave CXCR1 receptors, impairing chemotaxis

Triggers TLR2 activation → IL-8 release → recruits more neutrophils
→ perpetuates a vicious inflammatory cycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does the CFTR gene do?

A

Encodes a Cl⁻ and bicarbonate ion channel, regulating mucus hydration and epithelial transport

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Summarise the vicious cycle of inflammation in CF lungs.

A

Dead neutrophils → protease release → CXCR1 cleavage → neutrophil dysfunction → TLR2 activation → IL-8 release → more neutrophils → cycle repeats

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the inheritance pattern of CF?

A

Autosomal recessive – both parents must be carriers for a child to inherit CF (25% chance if both are carriers)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How is CF diagnosed?

A

Sweat test: measures Na⁺ and Cl⁻ in sweat

Chest X-rays and FEV1 tests: assess lung function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What types of mutations can affect the CFTR gene?

A

Deletion

Missense

Frameshift

Nonsense

Splicing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the mechanism of Levofloxacin?

A

Targets DNA gyrase (Topoisomerase II) → inhibits DNA replication in bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does Tobramycin work?

A

Inhaled aminoglycoside

Binds 30S & 50S ribosomes → inhibits 70S complex formation → no protein synthesis

Effective against P. aeruginosa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How does Dornase alfa work?

A

Inhaled therapy that thins mucus by breaking down DNA → improves cough clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the role of Mannitol in CF?

A

nhaled dry powder that increases osmolarity

Stimulates mediator release → enhances mucus clearance via coughing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What does Ivacaftor do?

A

Increases probability of CFTR channel opening → improves Cl⁻ transport

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the role of Ivacaftor + Lumacaftor or Tezacaftor?

A

Corrector drugs: help traffic CFTR to the membrane so it can function properly

14
Q

What is Trikafta (Ivacaftor + Tezacaftor + Elexacaftor)?

A

Triple combination therapy

Binds multiple sites on CFTR → improves trafficking and function

Increases lung function and life expectancy

15
Q

Why does pancreatic insufficiency occur in CF and what are the consequences?

A

Insufficient enzyme secretion → malabsorption of fats/proteins

Leads to cachexia and worsened infection risk

16
Q

What enzymes are supplemented in pancreatic therapy for CF?

A

Amylase: starch breakdown

Lipase: lipid breakdown

Protease: protein breakdown

Delivered via pH-sensitive, enteric-coated preparations

17
Q

What supportive therapies are used in CF?

A

Exercise

Chest physiotherapy to stimulate coughing

Lung transplantation (less common now with advanced therapies)

18
Q

What is the key difference between the innate and adaptive immune responses?

A

Innate: Rapid, stereotyped, no memory

Adaptive: Slower, highly specific, has memory and recall

19
Q

What are PAMPs and how are they detected?

A

PAMPs (pathogen-associated molecular patterns) are microbial markers detected by pattern recognition receptors (PRRs) such as TLRs, NLRs, RLRs, and CLRs.

20
Q

What is the role of the mucociliary escalator in lung defence?

A

It sweeps mucus and trapped pathogens upward at 1–2 cm/min using cilia. Viscosity or toxic exposures (e.g., smoke) can impair its function.

21
What is ARDS and what causes it in COVID-19?
Acute respiratory distress syndrome (ARDS) is severe lung inflammation causing fluid leakage into alveoli. In COVID-19, it's triggered by cytokine storm and immune dysregulation following SARS-CoV-2 infection.
22
What are key features of ARDS?
Reduced lung volume Low compliance (“stiff lungs”) Refractory hypoxemia Dyspnoea and tachypnoea Often follows viral pneumonia or sepsis
23
What is the effect of oxygen therapy in ARDS?
While necessary, high O₂ can cause hyperoxic injury, and mechanical ventilation can cause barotrauma.
24
What are current strategies for managing COVID-19?
Social distancing Vaccination (slow development, varied efficacy) Monoclonal antibodies (e.g., anti-Spike) Post-infection IgG therapy (short-term passive immunity)
25
What is the danger of unregulated therapeutic claims during a pandemic?
They promote ineffective or dangerous treatments, such as hydroxychloroquine or untested “light machines,” risking patient safety.
26
What is the purpose of adaptive clinical trials during a pandemic?
To quickly assess multiple treatments simultaneously, adjusting based on emerging data, and speeding up identification of effective therapies.
27
What challenge does vaccine development face during a pandemic?
Time: Typically 12–18 months Uncertainty: Efficacy can vary by age, comorbidities, and virus mutations
28
How does the FDA Modernization Act 2.0 influence pandemic preparedness?
It encourages faster approval processes and broader use of alternative research models (e.g., AI, organ-on-chip) to accelerate therapy development.
29
What can impair mucociliary clearance?
Increased mucus viscosity Reduced ciliary beat frequency Uncoupling of mucus and cilia Insufficient hydration of airway surface
30
How does SARS-CoV-2 cause lung damage?
Infects respiratory epithelium, triggers cytokine release (especially IL-6), leading to inflammation, vascular leakage, and ARDS in severe cases
31
What is the role of IL-6 in COVID-19 pathology?
IL-6 drives inflammation and is a target for therapies: Dexamethasone: inhibits IL-6 production Baricitinib: JAK inhibitor, blocks IL-6 signalling Tocilizumab: monoclonal antibody, neutralises IL-6
32
What are current antiviral and anti-inflammatory drugs used in COVID-19?
Antivirals: Remdesivir, Molnupiravir, Nirmatrelvir + Ritonavir Anti-inflammatories: Dexamethasone, Baricitinib, Tocilizumab
33
What is the role of monoclonal antibodies in COVID-19 treatment?
Target Spike protein to neutralise virus: Sotrovimab: for progression prevention Tixagevimab/Cilgavimab: for immunosuppressed prophylaxis
33
Why was hydroxychloroquine use in COVID-19 controversial
Despite being promoted, clinical trials showed no benefit, and it had potential risks. Its use was based on poor evidence
34
Why is drug repurposing important during pandemics?
New drug development is too slow (can take years), so repurposing existing drugs allows quicker therapeutic rollout
35
What is an adaptive clinical trial and why is it useful in pandemics?
A flexible trial that adapts to emerging data, allowing simultaneous testing of multiple interventions and faster identification of effective therapies
36
What does the FDA Modernization Act 2.0 promote?
Encourages use of non-animal models, accelerated approval processes, and innovative trial designs to respond quickly to emerging health threats